Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prevalence of cytomegalovirus antiviral drug resistance in transplant recipients.

Antiviral research - 1 Jul 2023

Kleiboeker Steven B

Abstract excerpt

Cytomegalovirus (CMV) is a significant human pathogen, especially for immunocompromised patients, often treated with one or more antiviral drugs. Although the prevalence of resistance is low, the impact of drug resistant CMV infections on patient outcomes is high and genotypic testing is recommended when resistance is suspected. To assess the prevalence of CMV drug resistance mutations among samples submitted for...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Benzimidazoles
Share to Cytomegalovirus
Share to DNA-Directed DNA Polymerase

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Viral

Share to Foscarnet

Share to Ganciclovir

Share to Transplant Recipients

Share to Viral Proteins

Source

Identifiers

PMID: 37150409
DOI: 10.1016/j.antiviral.2023.105623

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prevalence of cytomegalovirus antiviral drug resistance in transplant recipients.PMID 37150409Read ↗

Drug-resistant cytomegalovirus in transplant recipients: a French cohort study.Semantic proximity Read ↗

Drug-resistant cytomegalovirus: clinical implications of specific mutations.Semantic proximity Read ↗

Detection of cytomegalovirus drug resistance mutations in solid organ transplant recipients with suspected resistance.Semantic proximity Read ↗

Approach to drug-resistant cytomegalovirus in transplant recipients.Semantic proximity Read ↗

Drug Resistance Assessed in a Phase 3 Clinical Trial of Maribavir Therapy for Refractory or Resistant Cytomegalovirus Infection in Transplant Recipients.Semantic proximity Read ↗

The biology of cytomegalovirus drug resistance.Semantic proximity Read ↗

Cytomegalovirus antiviral resistance: characterization of results from clinical specimens.Semantic proximity Read ↗

Cytomegalovirus drug resistance mutations in transplant recipients with suspected resistance.Semantic proximity Read ↗

The emergence of letermovir and maribavir drug-resistant mutations: from clinical trials to real-world studies.Semantic proximity Read ↗

Intra-host diversity of drug-resistant cytomegalovirus: A case report of cytomegalovirus infection after allogeneic hematopoietic cell transplantation.Semantic proximity Read ↗

Use of next-generation sequencing to detect mutations associated with antiviral drug resistance in cytomegalovirus.Semantic proximity Read ↗

How I treat resistant cytomegalovirus infection in hematopoietic cell transplantation recipients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.